Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases.
Compass Therapeutics has raised $120.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in August 2025.
Compass Therapeutics's investors include Alumni Ventures, Founders Fund, Vivo Capital, Janus Henderson Investors, Polaris Partners.
Compass Therapeutics is headquartered in Boston, United States.
Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases.
Compass Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Compass Therapeutics — Funding & Investors." VCBacked, August 12, 2025, https://www.vcbacked.co/company/compass-therapeutics. Accessed July 19, 2026.
VCBacked. (2025). Compass Therapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/compass-therapeutics
{{cite web |title=Compass Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/compass-therapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated